Find a story
Search Spins
Search titles, summaries, and missing voices across published articles — press releases, announcements, and media coverage.
15 results for “biotech”
Icon inks Anthropic deal to deploy Claude into clinical trials - Fierce Biotech
Icon, a clinical research organization, has partnered with Anthropic to integrate Claude AI into clinical trial operations, aiming to improve trial design, documentation, and regulatory compliance.
Aug 5, 2026
FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
FibroBiologics announced it has dosed the first patients in a phase 1/2 clinical trial for CYWC628, its lead wound care candidate targeting diabetic foot ulcers, and expects interim results in the second half of 2026.
Aug 1, 2026
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
A press release from MindWalk Holdings Corp. (NASDAQ: HYFT) announces its appearance at a major computing event to signal strategic positioning in AI-driven drug discovery, though no specific product launch, clinical validation, or technical milestone is disclosed.
Jul 24, 2026
Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
A U.S. biotech firm chose to list in Hong Kong before Wall Street, reflecting a strategic pivot toward Asian capital markets and Chinese pharma collaboration.
Jul 22, 2026
Biotech IPO Gains Crush AI Listings With Standout 55% Return - Bloomberg.com
Biotech initial public offerings outperformed AI-related IPOs in the reporting period, delivering a 55% average return compared to weaker returns from AI listings.
Jul 21, 2026
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
Krystal Biotech, a biotechnology company, is being added to the S&P MidCap 400 index, replacing a homebuilding firm — a routine index rebalancing decision reflecting market capitalization and liquidity criteria.
Jul 21, 2026
Kalshi is offering wagers on the outcomes of late-stage clinical drug trials and regulatory decisions, launching a pilot of 13 new biotech contracts (Madison Muller/Bloomberg)
Kalshi, a prediction market platform, launched a pilot offering financial wagers on outcomes of late-stage clinical drug trials and regulatory decisions — introducing speculative trading into high-stakes biomedical decision-making.
Jul 17, 2026
Summit sells failed antibiotic to OpenAI-backed startup in $105M deal - Fierce Biotech
Summit Therapeutics sold rights to a failed antibiotic candidate to an OpenAI-backed startup for $105 million, signaling a strategic pivot from clinical failure to AI-driven drug repurposing.
Jul 14, 2026
This Biotech Lets Rare-Disease Families Invest In Its Gene Therapy - Forbes
A biotech company has created a novel investment model allowing families affected by rare diseases to directly fund and participate in the development of gene therapies targeting those conditions.
Jul 14, 2026
Reed Jobs would rather talk about curing cancer than his last name
Reed Jobs's biotech venture firm Yosemite has grown to 17 people and integrated AI deeply into its drug discovery workflow amid a wave of expiring blockbuster drug patents, positioning itself to capitalize on newly opened therapeutic opportunities.
Jul 12, 2026
U.S. Biotechs Are Keeping More Secrets to Beat Copycats in China - WSJ
U.S. biotechnology firms are increasing secrecy around R&D and manufacturing processes to prevent intellectual property theft by Chinese competitors, reflecting a strategic shift in response to perceived IP vulnerabilities.
Jul 11, 2026
I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned - STAT
Anthropic's CEO discussed speculative applications of AI in biotech during an interview with STAT, highlighting potential future impacts without reporting on concrete deployments, products, or verified outcomes.
Published Jul 6, 2026 · Analyzed Jul 8, 2026
Nona Biosciences Appoints Dr. Peng Wang as Chief Operating Officer to Advance Platform Capabilities and Drive Operational Excellence
Nona Biosciences, a biotech company focused on AI-enabled biotherapeutic discovery, appointed Dr. Peng Wang as COO to strengthen operational execution amid platform development and scaling efforts.
Published Jul 3, 2026 · Analyzed Jul 6, 2026
Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
Northwest Biotherapeutics announces scientific presentation on propensity score matching at British Neuro-Oncology Society Annual Meeting.
Published Jul 2, 2026 · Analyzed Jul 5, 2026
This Biotech Startup Just Raised $255 Million To Make Its AI-Designed Drug A Reality - Forbes
A biotech startup secured $255 million in funding to advance an AI-designed drug candidate into clinical development, signaling investor confidence in AI-driven drug discovery.
Published Jun 22, 2021 · Analyzed Jul 7, 2026